FDA won't disqualify HIV doctor from drug studies

Federal regulators decided not to disqualify a prominent North Side HIV doctor whose clinic submitted fictitious data in a drug trial.

Instead, the Food and Drug Administration agreed to allow Dr. Daniel Berger to continue working on drug trials as long as an outside medical monitor periodically reviews his work for three years.

"I feel as if I've been vindicated," Berger said. "A big weight has been lifted off my shoulders, and I'm able to do my life's work."